Follow
Loveleen Bansi-Matharu
Loveleen Bansi-Matharu
Institute for Global Health, UCL
Verified email at ucl.ac.uk
Title
Cited by
Cited by
Year
Impact of late diagnosis and treatment on life expectancy in people with HIV-1: UK Collaborative HIV Cohort (UK CHIC) Study
M May, M Gompels, V Delpech, K Porter, F Post, M Johnson, D Dunn, ...
Bmj 343, 2011
4742011
Potential effects of disruption to HIV programmes in sub-Saharan Africa caused by COVID-19: results from multiple mathematical models
BL Jewell, E Mudimu, J Stover, D Ten Brink, AN Phillips, JA Smith, ...
The lancet HIV 7 (9), e629-e640, 2020
4022020
When to initiate combined antiretroviral therapy to reduce mortality and AIDS-defining illness in HIV-infected persons in developed countries: an observational study
HIV-CAUSAL Collaboration*
Annals of internal medicine 154 (8), 509-515, 2011
3372011
Incidence of tuberculosis among HIV-infected patients receiving highly active antiretroviral therapy in Europe and North America
Antiretroviral Therapy Cohort Collaboration
Clinical Infectious Diseases 41 (12), 1772-1782, 2005
2822005
Sustainable HIV treatment in Africa through viral-load-informed differentiated care
A Phillips, A Shroufi, L Vojnov, J Cohn, T Roberts, T Ellman, K Bonner, ...
Nature 528 (7580), S68-S76, 2015
1672015
Outcome in renal Al amyloidosis after chemotherapy
JH Pinney, HJ Lachmann, L Bansi, AD Wechalekar, JA Gilbertson, ...
Journal of clinical oncology 29 (6), 674-681, 2011
1632011
Factors influencing efavirenz and nevirapine plasma concentration: effect of ethnicity, weight and co-medication
W Stöhr, D Back, D Dunn, C Sabin, A Winston, R Gilson, D Pillay, T Hill, ...
Antiviral therapy 13 (5), 675-685, 2008
1582008
Risks and benefits of dolutegravir-based antiretroviral drug regimens in sub-Saharan Africa: a modelling study
AN Phillips, F Venter, D Havlir, A Pozniak, D Kuritzkes, A Wensing, ...
The lancet HIV 6 (2), e116-e127, 2019
1162019
Late diagnosis in the HAART era: proposed common definitions and associations with mortality.
CA Sabin, A Schwenk, MA Johnson, B Gazzard, M Fisher, J Walsh, ...
AIDS (London, England) 24 (5), 723-727, 2010
1032010
Death rates in HIV-positive antiretroviral-naive patients with CD4 count greater than 350 cells per μL in Europe and North America: a pooled cohort observational study
RK Lodwick, CA Sabin, K Porter, B Ledergerber, A Van Sighem, ...
The Lancet 376 (9738), 340-345, 2010
972010
Declining prevalence of HIV-1 drug resistance in antiretroviral treatment-exposed individuals in Western Europe
A De Luca, D Dunn, M Zazzi, R Camacho, C Torti, I Fanti, R Kaiser, ...
The Journal of infectious diseases 207 (8), 1216-1220, 2013
892013
CD4 counts and the risk of systemic non-Hodgkin’s lymphoma in individuals with HIV in the UK
M Bower, M Fisher, T Hill, I Reeves, J Walsh, C Orkin, AN Phillips, L Bansi, ...
haematologica 94 (6), 875, 2009
882009
Immunodeficiency and renal impairment are risk factors for HIV-associated acute renal failure
F Ibrahim, C Naftalin, E Cheserem, J Roe, LJ Campbell, L Bansi, ...
Aids 24 (14), 2239-2244, 2010
802010
Discordant responses on starting highly active antiretroviral therapy: suboptimal CD4 increases despite early viral suppression in the UK Collaborative HIV Cohort (UK CHIC) Study
R Gilson, SL Man, A Copas, A Rider, S Forsyth, T Hill, L Bansi, K Porter, ...
HIV medicine 11 (2), 152-160, 2010
802010
Risk of extensive virological failure to the three original antiretroviral drug classes over long-term follow-up from the start of therapy in patients with HIV infection: an …
AN Phillips, C Leen, A Wilson, J Anderson, D Dunn, A Schwenk, C Orkin, ...
The Lancet 370 (9603), 1923-1928, 2007
782007
Associations between integrase strand-transfer inhibitors and cardiovascular disease in people living with HIV: a multicentre prospective study from the RESPOND cohort consortium
B Neesgaard, L Greenberg, JM Miró, K Grabmeier-Pfistershammer, ...
The lancet HIV 9 (7), e474-e485, 2022
642022
Antiretroviral therapy CNS penetration and HIV-1–associated CNS disease
L Garvey, A Winston, J Walsh, F Post, K Porter, B Gazzard, M Fisher, ...
Neurology 76 (8), 693-700, 2011
602011
The prevalence of hepatitis C virus (HCV) infection in HIV‐positive individuals in the UK–trends in HCV testing and the impact of HCV on HIV treatment outcomes
J Turner, L Bansi, R Gilson, B Gazzard, J Walsh, D Pillay, C Orkin, ...
Journal of viral hepatitis 17 (8), 569-577, 2010
592010
Trends over calendar time in antiretroviral treatment success and failure in HIV clinic populations*
L Bansi, C Sabin, V Delpech, T Hill, M Fisher, J Walsh, T Chadborn, ...
HIV medicine 11 (7), 432-438, 2010
592010
Rates of subsequent surgery following endometrial ablation among E nglish women with menorrhagia: population‐based cohort study
L Bansi‐Matharu, I Gurol‐Urganci, TA Mahmood, A Templeton, ...
BJOG: An International Journal of Obstetrics & Gynaecology 120 (12), 1500-1507, 2013
582013
The system can't perform the operation now. Try again later.
Articles 1–20